In a study of 76 locally advanced prostate cancer patients treated with RT, BCFFS was 39% for those with an initial PSA value ≤15 ng/mL and 0% for those with PSA values >15 ng/mL [21]. The gene discussed is KLK3; the disease is prostate carcinoma.